REDUSURE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Oct 2021)
What this means for you
Registered since 03 May 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was due 03 May 2026, and its grace period ended 03 Nov 2026 with no filing on the USPTO record).
Record
- Serial number
- 86451607
- Registration number
- 4952274
- Mark type
- Word mark
- Filed
- 12 Nov 2014
- Published for opposition
- 16 Jun 2015
- Registered
- 03 May 2016
- Next maintenance filing
- §8 & §9 renewal, due by 03 May 2026 (grace period to 03 Nov 2026)
- Attorney of record
- Mark D. Swanson
Goods and services
- Class 005 — Pharmaceuticals: Dietetic, Nutraceutical and Pharmaceutical preparations in tablet, capsule, powder or liquid form, namely, those for the treatment of metabolic syndrome related diseases, general weight management and the treatment of obesity; plant extracts for medical use, namely, extract of Amorphophallus konjac; pharmaceutical, nutraceutical or other preparations for the treatment or prevention of metabolic and related diseases, general weight management and/or treatment or prevention of obesity; Chemical preparations for medical and pharmaceutical purposes for the treatment or prevention of metabolic and related diseases, general weight management and/or treatment or prevention of obesity; dietary supplement; plant extracts adapted for dietetic, nutraceutical, healthcare, medical, nutritional and/or pharmaceutical use; plant extracts adapted for the treatment or prevention of metabolic and related diseases, general weight management and/or treatment or prevention of obesity; medicated food supplements; weight management supplements; nutraceuticals for use as a dietary supplement; nutritional supplements to reduce or control appetite; nutritional supplements for use in promoting satiety; nutritional food additives for medical purposes in the nature of food extracts derived from plants; nutritional supplement and meal replacement in tablet, capsule, powder or liquid form for reducing or controlling appetite; nutritional supplement and meal replacement in tablet, capsule, powder or liquid form for promoting satiety; appetite suppressants
Owner
- InQpharm Europe Limited, Hitchin, Hertfordshire, GB
- InQpharm Europe Limited, Hitchin, Hertfordshire, GB
- InQpharm Europe Limited, Hitchin, Hertfordshire, GB
Prosecution history
- 03 May 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Oct 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Oct 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Oct 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Jul 2021 — TEAS SECTION 8 & 15 RECEIVED
- 03 May 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 03 May 2016 — REGISTERED-PRINCIPAL REGISTER
- 26 Mar 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Mar 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Jan 2016 — USE AMENDMENT FILED
- 20 Feb 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Jan 2016 — TEAS STATEMENT OF USE RECEIVED
- 11 Aug 2015 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Jun 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED